1. Home
  2. PLRX vs OPXS Comparison

PLRX vs OPXS Comparison

Compare PLRX & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • OPXS
  • Stock Information
  • Founded
  • PLRX 2015
  • OPXS 1987
  • Country
  • PLRX United States
  • OPXS United States
  • Employees
  • PLRX N/A
  • OPXS N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • OPXS Electronic Components
  • Sector
  • PLRX Health Care
  • OPXS Technology
  • Exchange
  • PLRX Nasdaq
  • OPXS Nasdaq
  • Market Cap
  • PLRX 77.3M
  • OPXS 72.2M
  • IPO Year
  • PLRX 2020
  • OPXS N/A
  • Fundamental
  • Price
  • PLRX $1.39
  • OPXS $13.68
  • Analyst Decision
  • PLRX Hold
  • OPXS
  • Analyst Count
  • PLRX 10
  • OPXS 0
  • Target Price
  • PLRX $9.79
  • OPXS N/A
  • AVG Volume (30 Days)
  • PLRX 1.7M
  • OPXS 87.0K
  • Earning Date
  • PLRX 08-06-2025
  • OPXS 08-12-2025
  • Dividend Yield
  • PLRX N/A
  • OPXS N/A
  • EPS Growth
  • PLRX N/A
  • OPXS 36.84
  • EPS
  • PLRX N/A
  • OPXS 0.71
  • Revenue
  • PLRX N/A
  • OPXS $37,431,000.00
  • Revenue This Year
  • PLRX N/A
  • OPXS N/A
  • Revenue Next Year
  • PLRX N/A
  • OPXS N/A
  • P/E Ratio
  • PLRX N/A
  • OPXS $18.26
  • Revenue Growth
  • PLRX N/A
  • OPXS 21.76
  • 52 Week Low
  • PLRX $1.10
  • OPXS $5.36
  • 52 Week High
  • PLRX $16.10
  • OPXS $13.76
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 53.02
  • OPXS 70.50
  • Support Level
  • PLRX $1.13
  • OPXS $11.06
  • Resistance Level
  • PLRX $1.50
  • OPXS $13.00
  • Average True Range (ATR)
  • PLRX 0.11
  • OPXS 0.94
  • MACD
  • PLRX 0.03
  • OPXS 0.08
  • Stochastic Oscillator
  • PLRX 71.23
  • OPXS 95.05

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.

Share on Social Networks: